[PTGX] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
03-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -9.60%
YoY- -335.45%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 859 25,722 8,617 10,286 2,265 6,189 5,650 -71.61%
PBT -41,037 -20,930 -36,907 -33,804 -30,842 -23,998 -18,886 67.99%
Tax -406 -181 -832 122 -57 -79 -1,305 -54.18%
NP -40,631 -20,749 -36,907 -33,804 -30,842 -23,998 -18,886 66.88%
Tax Rate - - - - - - - -
Total Cost 41,490 46,471 45,524 44,090 33,107 30,187 24,536 42.07%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -4,730.03 -80.67 -428.30 -328.64 -1,361.68 -387.75 -334.27 487.87%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.83 -0.43 -0.77 -0.70 -0.69 -0.54 -0.48 44.20%
EPS Diluted -0.83 -0.43 -0.77 -0.70 -0.69 -0.54 -0.48 44.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.